Radioimmunotherapy of Cancer Using Monoclonal Antibodies to Target Radiotherapy

By  

Current Pharmaceutical Design, Vol. 6, Iss. 14, 2000-09 ,pp. : 1399-1418

Bentham Science Publishers

Access to resources Recommend Favorite

Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors

By Galsky Matthew  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 695-701

Springer Publishing Company

Access to resources Recommend Favorite

Dasatinib in solid tumors

By Kim Lori C   Rix Uwe   Haura Eric B  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 3, 2010-03 ,pp. : 415-425

Informa Healthcare

Access to resources Recommend Favorite

Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors

By Abu-Khalaf Maysa M.   Baumgart Megan A.   Gettinger Scott N.   Doddamane Indukala   Tuck David P.   Hou Shihe   Chen Nianhang   Sullivan Catherine   Lezon-Geyda Kimberly   Zelterman Daniel   Hatzis Christos   Deshpande Hari   Digiovanna Michael P.   Azodi Masoud   Schwartz Peter E.   Harris Lyndsay N.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1817-1826

Blackwell Publishing

Access to resources Recommend Favorite

Drug Delivery and Transport to Solid Tumors

By Jang Seong Hoon   Wientjes M. Guillaume   Lu Dan   Au Jessie L.-S.  

Pharmaceutical Research, Vol. 20, Iss. 9, 2003-09 ,pp. : 1337-1350

Springer Publishing Company

Access to resources Recommend Favorite